The present review provides an update on new research activities and data available on the health effects evaluation and physiologically based pharmacokinetic (PBPK) modeling of BPA. It includes discussions by researches that address some of the disparities between traditional regulatory studies and findings from independent academic investigators, with a focus on the Consortium Linking Academic and Regulatory Insights on BPA Toxicity program.
Date:
2022-06
Relation:
Reproductive and Developmental Toxicology. 2022 Jun:779-801.
